FEDCX | MEDCX | FEDCX / MEDCX | |
Total Expense Ratio | 0.00 | 1.81 | - |
Annual Report Gross Expense Ratio | 0.01 | 1.82 | 1% |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 4.532 | 3.729 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.41B | 7.23B | 19% |
Annual Yield % from dividends | 5.76 | 5.69 | 101% |
Returns for 1 year | 8.88 | 7.92 | 112% |
Returns for 3 years | 29.89 | 23.93 | 125% |
Returns for 5 years | 17.71 | 6.97 | 254% |
Returns for 10 years | 49.23 | 27.36 | 180% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CVAIX | 23.50 | 0.20 | +0.86% |
Calamos Select Fund I | |||
GSCYX | 17.07 | N/A | N/A |
GuideStone Funds Small Cap Equity Instl | |||
CMVYX | 13.54 | N/A | N/A |
Columbia Select Mid Cap Value Instl 3 | |||
PNAIX | 77.32 | N/A | N/A |
T. Rowe Price All-Cap Opportunities-I | |||
VPRDX | 16.36 | N/A | N/A |
VY® Morgan Stanley Global Franchise R6 |